𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Interventional EUS for the treatment of pancreatic cancer

✍ Scribed by Ashida, Reiko ;Chang, Kenneth J.

Publisher
Springer
Year
2009
Tongue
English
Weight
176 KB
Volume
16
Category
Article
ISSN
0944-1166

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Combined gemcitabine and radioimmunother
Combined gemcitabine and radioimmunotherapy for the treatment of pancreatic cancer
✍ Thomas M. Cardillo; Rosalyn Blumenthal; Zhiliang Ying; David V. Gold πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 French βš– 116 KB πŸ‘ 1 views

## Abstract MAb‐PAM4 is an anti‐MUC1 antibody that has been shown to be reactive with 85% of pancreatic adenocarcinomas with no reactivity with normal pancreas or other tissues. Initial clinical studies have shown excellent targeting with high tumor/nontumor ratios. Gemcitabine, an analog of deoxyc

Combined modality treatment of pancreati
Combined modality treatment of pancreatic cancer: Implications for the surgeon
✍ Dr. Urs F. Metzger; Daniel L. Kisner; Bimal C. Ghosh πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 618 KB

Since pancreatic cancer is still increasing and has a poor prognosis, there is great interest in improving treatment results by combined modality approaches. This paper considers the most appropriate studies to analyze the status of treatment and future implications for surgeons. With new radiation